The HER2 gene regulates the growth of cancer cells.
HER2基因可以调节肿瘤细胞的生长速度。
This helps to stop the growth of HER2 cancer cells.
这个可以有助于阻止HER2所致的肿瘤细胞的生长。
Methods: Immunohistochemistry was used to detect HER2 expression in 110 cases of breast carcinoma.
方法：应用免疫组织化学方法，检测110例乳腺癌组织中her 2蛋白表达，结合随访资料分析。
Expression of HER2 is associated with clinicopathological features in the gastroesophageal cancer.
HER2在胃食管结合部癌中的表达与临床病理特征关系密切。
In HER2-positive breast cancer, stimulation of the HER2 receptor contributes to cancer cell growth.
在HER 2阳性的乳腺癌患者中，HER2受体受到刺激后也能促进癌细胞增长。
The new drug is targeted to treat breast cancers that carry a special genetic marker, known as HER2.
这种新药是用于治疗乳腺癌，这种携带了表皮生长因子受体2（Her-2）的特异生物标记的疾病。
The researchers then looked at the drug Herceptin, which is used to treat HER2-positive breast cancer.
研究者们研究被用来治疗HER2阳性乳腺癌症的药物赫赛汀。
The survival experience of HER2 and ER were significant among each grade of them. (P< 0. 01, P< 0. 01) .
HER2和ER各级表达与生存率曲线比较，统计学有显著差异，P均小于0.01。
A three-dimensional pharmacophore model of two types of HER2 inhibitors was obtained by using the CATALYST software.
通过CATALYST软件包得到了两类HER2抑制的三维药效团模型。
HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer.
HER2的异质性会影响HER 2阳性转移性乳腺癌患者曲妥珠单抗的效果和生存期。
The girl ran up to the old woman, took the basket from her2 and said, "Old granny, let me go with you to your son's home."
这个小女孩跑到老奶奶跟前，接过篮子说：“老奶奶，让我送你到你儿子家去吧。”
Nor did Herceptin have any effect on the HER2-negative cells, which is consistent with how Herceptin is used in the clinic.
赫赛汀对HER 2阴性的细胞也没有任何作用，即使在临床上赫赛汀的用量保持一致。
HER2 is a protein involved in normal cell growth. It is found on some types of cancer cells, including breast cancer cells.
HER2是维持细胞正常生长的一种蛋白质，也存在于某些癌细胞，如乳腺癌。
Perhaps the most famous of all targeted therapeutics is Genentech's (NYSE: DNA) Herceptin, which inhibits the HER2 receptor.
所有靶向治疗中最负盛名的可能就是基因泰克（Genentech）的Herceptin，该药可抑制HER2受体。
Methods The expression of HER2, MMP2, MMP9 was detected by immunohistochemical staining in 114 specimens of breast cancer patients.
方法采用免疫组织化学的方法对114例乳腺癌组织标本中HER2、MMP 2、MMP 9的表达情况进行检测。
That was proved two years ago, when three large trials showed Herceptin's value in treating early-stage Her2-positive breast cancer.
这在两年前就得到证明，当三个大型试验显示了贺癌平在治疗早期Her阳性乳腺癌方面的价值。
A total of 210 women with early breast cancer who tested positive for human epidermal growth factor receptor 2 (HER2) were enrolled.
共有210名患有人表皮生长因子受体2 (HER2)阳性的早期乳腺癌的女性患者参加了实验。
Tykerb works by depriving tumor cells of signals needed to grow. Tykerb enters the cell and blocks the function of the HER2 protein.
拉帕替尼能阻断肿瘤细胞生长的信号，进入细胞后能阻止HER2蛋白发挥作用。
Triple-negative breast cancers are breast cancers that have tested negative for estrogen receptors, progesterone receptors and HER2.
三阴性乳腺癌是雌激素受体、孕酮受体和HER2检测皆为阴性的乳腺癌。
Are most of the cases with unstable expression of er, either gains or losses, occurring in patients with HER2-positive primary tumors?
“她问道：”大多数ER不稳定表达的病例，或者获得或丢失，在HER 2阳性原发肿瘤病人也发生吗？
Further, the drug Herceptin, which is used to treat HER2-positive breast cancer, was found to target and destroy the cancer stem cells.
此外，发现用于治疗HER 2阳性乳腺癌的药物赫赛汀，能够靶向和摧毁癌症干细胞。
Objective To study the feasibility of adenoviral transduction of Herceptin complete antibody gene and its effect on Her2 over expressing cancer.
目的探讨应用基因治疗方法表达完全抗体的可行性及其对肿瘤的治疗作用。
The FDA approval of Tykerb was based on the results of a study involving approximately 400 breast cancer patients with advanced-stage HER2 disease.
FDA参照大约400例晚期her 2阳性的乳腺癌病例的研究结果的基础上，批准了拉帕替尼应用于临床。
According to the FDA, Tykerb inhibits tumor growth by going inside cells containing the HER2 protein and blocking signals that promote tumor growth.
根据FDA提供的资料，拉帕替尼通过进入表达HER2蛋白的细胞，阻滞促进肿瘤生长的信号。
Objective To analyse the clinical and pathological Characteristics of HER2 expression and observe prognostic significance of HER-2 in breast cancer .
目的：分析HER2表达的临床意义及病理特征，观察HER2表达对乳腺癌预后的影响。
In estrogen receptor (er) -negative tumors, AR was distinctively associated with human epidermal growth factor receptor type 2 (HER2) overexpression.
雌激素受体(ER)阴性的肿瘤，AR明显与人表皮生长因子受体2型(her2)的过度表达相关。
Overexpression of HER2 may be associated with high histologic grade, er - tumors, greater proliferation, larger tumor size, and thus a poor prognosis.
HER2的过分表达可能与组织学等级高、ER-肿瘤、增生扩大、肿瘤较大及因此而致的预后不良有关。
Overexpression of HER2 may be associated with high histologic grade, er - tumors, greater proliferation, larger tumor size, and thus a poor prognosis.
HER2的过分表达可能与组织学等级高、ER-肿瘤、增生扩大、肿瘤较大及因此而致的预后不良有关。
应用推荐